DrugDashboards

A-1

CAPRA HIRCUS SKIN, FELIS CATUS SKIN, BOS TAURUS SKIN, CANIS LUPUS FAMILIARIS SKIN, EQUUS CABALLUS SKIN, CAPRA HIRCUS HAIR, and Sheep Wool · CAPRA HIRCUS SKIN 30 [hp_X]/mL; FELIS CATUS SKIN 30 [hp_X]/mL; BOS TAURUS SKIN 30 [hp_X]/mL; CANIS LUPUS FAMILIARIS SKIN 30 [hp_X]/mL; EQUUS CABALLUS SKIN 30 [hp_X]/mL; CAPRA HIRCUS HAIR 30 [hp_X]/mL; SHEEP WOOL 30 [hp_X]/mL · Solution · Sublingual · DNA Labs, Inc.

NDC 58264-0293-01 · 29.57 mL in 1 BOTTLE, GLASS · UNAPPROVED HOMEOPATHIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of CAPRA HIRCUS SKIN, FELIS CATUS SKIN, BOS TAURUS SKIN, CANIS LUPUS FAMILIARIS SKIN, EQUUS CABALLUS SKIN, CAPRA HIRCUS HAIR, and Sheep Wool (Solution)

LabelerStrengthFirst seenLast seen
DNA Labs, Inc.CAPRA HIRCUS SKIN 30 [hp_X]/mL; FELIS CATUS SKIN 30 [hp_X]/mL; BOS TAURUS SKIN 30 [hp_X]/mL; CANIS LUPUS FAMILIARIS SKIN 30 [hp_X]/mL; EQUUS CABALLUS SKIN 30 [hp_X]/mL; CAPRA HIRCUS HAIR 30 [hp_X]/mL; SHEEP WOOL 30 [hp_X]/mLJul 22, 2026Sep 2, 2026
DNA Labs, Inc.BOS TAURUS SKIN 30 [hp_X]/mL; CANIS LUPUS FAMILIARIS SKIN 30 [hp_X]/mL; CAPRA HIRCUS HAIR 30 [hp_X]/mL; CAPRA HIRCUS SKIN 30 [hp_X]/mL; EQUUS CABALLUS SKIN 30 [hp_X]/mL; FELIS CATUS SKIN 30 [hp_X]/mL; SHEEP WOOL 30 [hp_X]/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "A-1 — NDC 58264-0293-01," retrieved September 3, 2026, https://drugdashboards.com/drug/58264029301.

Free to cite with attribution — see how the data is put together.